M45.7
Ankylosing spondylitis of lumbosacral region
Clinical Classification Guidelines
Medical Intelligence & Overview
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. When it impacts the lumbosacral region, which includes the lower part of the spine and the pelvis, it can cause significant discomfort and mobility issues. This condition is characterized by inflammation, pain, and potential fusion of the affected joints, leading to stiffness and reduced flexibility. Recognizing the signs and understanding the typical progression can help in managing symptoms effectively and improving quality of life.
Causes & Symptoms
Clinical Causes: Genetic factors, especially the presence of the HLA-B27 gene Autoimmune responses where the body’s immune system mistakenly attacks spinal tissues Environmental triggers such as infections that might initiate or exacerbate inflammation Gender differences, with a higher prevalence in males Age of onset typically in late adolescence or early adulthood
Key Symptoms: Chronic back pain and stiffness, especially in the lower back and hips Pain that worsens with rest and improves with activity Limited range of motion in the lower back and hips Postural changes, such as a forward-stooped posture in advanced stages Fatigue and general feeling of being unwell In some cases, inflammation may spread to other joints, tendons, and organs
Diagnostic & Treatment
Diagnosis Path: Diagnosing ankylosing spondylitis involving the lumbosacral region includes a combination of clinical evaluation, imaging, and laboratory tests. Healthcare providers may use the following methods: - Medical history review focusing on symptom duration and family history - Physical examination assessing flexibility, posture, and joint tenderness - Imaging studies, such as X-rays or MRI scans, to visualize joint inflammation, erosion, or fusion - Blood tests to detect markers of inflammation like elevated ESR or CRP, and genetic testing for HLA-B27 Early diagnosis can be challenging, but prompt detection is crucial for managing progression and preventing severe deformities.
Treatment Protocols: While there is no cure for ankylosing spondylitis, several treatments aim to alleviate symptoms and keep joints functional: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Physical therapy focusing on maintaining posture, flexibility, and strength - Regular exercise routines tailored by health professionals - Disease-modifying medications, such as biologic agents, in more severe cases - Pain management strategies - In some instances, surgical intervention might be considered for severe deformities or joint damage Effective management often involves a multidisciplinary approach to address pain, mobility, and overall health.
Clinical Advice & FAQs
Billing Guidance
Is M45.7 a billable ICD-10 code?
Yes, M45.7 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M45.7?
Clinical documentation must specify the nature of Ankylosing spondylitis of lumbosacral region and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
